NCAM1 and vitiligo: Semi-quantification of their detection has shown significantly higher number of CD56 + Granzyme B+ cells and CD56 + IFNγ+cells in NL compared to L skin of vitiligo patients (n = 6) and a higher number in NL skin of vitiligo patients compared to healthy skin (n = 5) (Fig. 1a, b).